Familial pancreatic cancer: current status

Bibliography

• COOPERMAN AM: Pancreatic cancer: the bigger picture. Surg. Clin. North Am. (2001) 81:557-574.
   PubMed Web of Science ®Google Scholar
• LYNCH HT, LANSPA SJ, FITZGIBBONS RJ Jr et al.: Familial pancreatic cancer (Part 1): genetic pathology review. Nebr. Med. J. (1989) 74(5):109-112.
   PubMedGoogle Scholar
• BARTSCH DK, KRESS R, SINA-FREY M et al.: Prevalence of familial pancreatic cancer in Germany. Int. J. Cancer (2004) 110(6):902-906.
   PubMed Web of Science ®Google Scholar
• HEMMINKI K, LI X: Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int. J. Cancer (2003) 103(4):525-530.
   PubMed Web of Science ®Google Scholar
• JENNE DE, REIMANN H, NEZU J et al.: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. (1998) 18(1):38-43.
   PubMed Web of Science ®Google Scholar
• SU GH, HRUBAN RH, BANSAL RK et al.: Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am. J. Pathol. (1999) 154(6):1835-1840
   PubMed Web of Science ®Google Scholar
• GIARDIELLO FM, WELSH SB, HAMILTON SR et al.: Increased risk of cancer in the Peutz-Jeghers syndrome. N. Engl. J. Med. (1987) 316824):1511-1514.
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN AM, FRASER MC, STRUEWING JP et al.: Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N. Engl. J. Med. (1995) 333(15):970-974.
   PubMed Web of Science ®Google Scholar
• VASEN HF, GRUIS NA, FRANTS RR et al.: Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int. J. Cancer (2000) 87(6):809-811.
   PubMed Web of Science ®Google Scholar
• WHELAN AJ, BARTSCH D, GOODFELLOW PJ: Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N. Engl. J. Med. (1995) 333(15):975-977.
   PubMed Web of Science ®Google Scholar
• MOSKALUK CA, HRUBAN H, LIETMAN A et al.: Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Mutations in brief no. 148. Hum. Mutat. (1998) 12(1):70.
   PubMedGoogle Scholar
• LYNCH HT, BRAND RE, HOGG D et al.: Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer (2002) 94(1):84-96.
   PubMed Web of Science ®Google Scholar
• BARTSCH DK, SINA-FREY M, LANG S et al.: CDKN2A germline mutations in familial pancreatic cancer. Ann. Surg. (2002) 236(6):730-737.
   PubMed Web of Science ®Google Scholar
• TONIN P, GHADIRIAN P, PHELAN C et al.: A large multisite cancer family is linked to BRCA2. J. Med. Genet. (1995) 32(12):982-984.
   PubMed Web of Science ®Google Scholar
• SIMARD J, TONIN P, DUROCHER F et al.: Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat. Genet. (1994) 8(4):392-398.
   PubMed Web of Science ®Google Scholar
• THOMPSON D, EASTON DF; for the BREAST CANCER LINKAGE CONSORTIUM: Cancer incidence in BRCA1 mutation carriers. J. Natl. Cancer Inst. (2002) 94(18):1358-1365.
   PubMed Web of Science ®Google Scholar
• RISCH HA, MCLAUGHLIN JR, COLE DE et al.: Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am. J. Hum. Genet. (2001) 68(3):700-710.
   PubMed Web of Science ®Google Scholar
• OZCELIK H, SCHMOCKER B, DI NICOLA N et al.: Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat. Genet. (1997) 16(1):17-18.
   PubMed Web of Science ®Google Scholar
• THE BREAST CANCER LINKAGE CONSORTIUM: Cancer risks in BRCA2 mutation carriers. J. Natl. Cancer Inst. (1999) 91:1310-1316.
   PubMed Web of Science ®Google Scholar
• LYNCH HT, BRAND RE, DETERS CA et al.: Hereditary pancreatic cancer. Pancreatology (2001) 1(5):466-471.
   PubMed Web of Science ®Google Scholar
• LEACH FS, NICOLAIDES NC, PAPADOPOULOS N et al.: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 75(6):1215-1225.
   PubMed Web of Science ®Google Scholar
• FISHEL R, LESCOE MK, RAO MR et al.: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell (1993) 75:1027-1028.
   PubMed Web of Science ®Google Scholar
• AARNIO M, SANKILA R, PUKKALA E et al.: Cancer risk in mutation carriers of DNA-mismatchrepair genes. Int. J. Cancer (1999) 81(2):214-218.
   PubMed Web of Science ®Google Scholar
• HRUBAN RH, PETERSEN GM, HA PK et al.: Genetics of pancreatic cancer. From genes to families.Surg. Oncol. Clin N. Am. (1998) 7(1):1-23.
   PubMed Web of Science ®Google Scholar
• LYNCH HT, VOORHEES GJ, LANSPA SJ et al.: Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br. J. Cancer (1985) 52:271-273.
   PubMed Web of Science ®Google Scholar
• LYNCH HT: Genetics and pancreatic cancer. Arch. Surg. (1994) 129(3):266-268.
   PubMed Web of Science ®Google Scholar
• SINA-FREY M, BARTSCH DK, GRUNDEI T et al.: Pancreatic cancer and basal-cell carcinoma [letter]. Lancet (2003) 361(9352):180.
   PubMedGoogle Scholar
• WHITCOMB DC, GORRY MC, PRESTON RA et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat. Genet. (1996) 14(2):141-145.
   PubMed Web of Science ®Google Scholar
• WITT H, LUCK W, HENNIES HC et al.: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat. Genet. (2000) 25(2):213-216.
   PubMed Web of Science ®Google Scholar
• LOWENFELS AB, MAISONNEUVE P, WHITCOMB DC: Risk factors for cancer in hereditary pancreatitis. International hereditary pancreatitis study group. Med. Clin North Am.(2000) 84(3):565-573.
   PubMed Web of Science ®Google Scholar
• LOWENFELS AB, MAISONNEUVE P, WHITCOMB DC et al.: Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA (2001) 286(2):169-170.
   PubMed Web of Science ®Google Scholar
• LOWENFELS AB, MAISONNEUVE P: Risk factors for pancreatic cancer. J. Cell Biochem. (2005) 95(4):649-656.
   PubMed Web of Science ®Google Scholar
• LERCH MM, ELLIS I, WHITCOMB DC et al.: Maternal inheritance pattern of hereditary pancreatitis in patients with pancreatic carcinoma. J. Natl. Cancer Inst. (1999) 91(8):723-724.
   PubMed Web of Science ®Google Scholar
• HOWES N, LERCH MM, GREENHALF W et al.: European registry of hereditary pancreatitis and pancreatic cancer (EUROPAC) clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin. Gastroenterol. Hepatol. (2004) 2(3):252-261.
   PubMed Web of Science ®Google Scholar
• TEDESCO FJ, BROWN R, SCHUMAN BM: Pancreatic carcinoma in a patient with cystic fibrosis. Gastrointest. Endosc. (1986) 32(1):25-26.
   PubMed Web of Science ®Google Scholar
• TSONGALIS GJ, FABER G, DALLDORF FG et al.: Association of pancreatic adenocarcinoma, mild lung disease, and delta F508 mutation in a cystic fibrosis patient. Clin. Chem. (1994) 40(10):1972-1974.
   PubMed Web of Science ®Google Scholar
• APPLEBAUM SE, KANT JA, WHITCOMB DC et al.: Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Med. Clin. North Am. (2000) 84(3):575-588.
   PubMed Web of Science ®Google Scholar
• BARTSCH DK, SINA-FREY M, ZIEGLER A et al.: Update of familial pancreatic cancer in Germany. Pancreatology (2001) 1(5):510-516.
   PubMed Web of Science ®Google Scholar
• TERSMETTE AC, PETERSEN GM, OFFERHAUS GJ et al.: Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin. Cancer Res. (2001) 7:738-744.
   PubMed Web of Science ®Google Scholar
• KLEIN AP, BRUNE KA, PETERSEN GM et al.: Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. (2004) 64(7):2634-2638.
   PubMed Web of Science ®Google Scholar
• WANG W, CHEN S, BRUNE KA, HRUBAN RH, PARMIGIANI G, KLEIN AP: PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J. Clin. Oncol. (2007) 25(11):1417-1422.
   PubMed Web of Science ®Google Scholar
• MCFAUL C, GREENHALF W, EARL J et al.: Anticipation in familial pancreatic cancer. Gut (2006) 55:252-258.
   PubMed Web of Science ®Google Scholar
• BRUNE K, ABE T, CANTO M et al.: Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am. J. Surg. Pathol. (2006) 30(9):1067-1076.
   PubMed Web of Science ®Google Scholar
• KLEIN AP, BEATY TH, BAILEY-WILSON JE et al.: Evidence for a major gene influencing risk of pancreatic cancer. Genet. Epidemiol. (2002) 23(2):133.
   PubMed Web of Science ®Google Scholar
• EBERLE MA, PFUTZER R, POGUE-GEILE KL et al.: A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am. J. Hum. Genet. (2002) 70(4):1044-1048.
   PubMed Web of Science ®Google Scholar
• EARL J, YAN L, VITONE LJ et al.; EUROPEAN REGISTRY OF HEREDITARY PANCREATITIS AND FAMILIAL PANCREATIC CANCER; KRESS R, SINA-FREY M, HAHN SA, RIEDER H, BARTSCH DK; GERMAN NATIONAL CASE COLLECTION FOR FAMILIAL PANCREATIC CANCER: Evaluation of the 4q32-34 locus in European familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. (2006) 15(10):1948-1955.
   PubMed Web of Science ®Google Scholar
• KLEIN AP, DE ANDRADE M, HRUBAN RH et al.: Linkage analysis of chromosome 4 in families with familial pancreatic cancer. Cancer Biol. Ther. (2007) 6(3):320-323.
   PubMed Web of Science ®Google Scholar
• POGUE-GEILE KL, CHEN R, BRONNER MP et al.: Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. (2006) 3(12):E516.
   PubMed Web of Science ®Google Scholar
• SLATER E, AMRILLAEVA V, FENDRICH V et al.: Palladin mutation causes familial pancreatic cancer: absence in European families. PLoS Med. (2007) 4(4):E164.
   PubMed Web of Science ®Google Scholar
• ZOGOPOULOUS G, ROTHENMUND H, EPPEL A et al.: The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer. Hum. Genet. (2007) 121(5):635-637.
   PubMed Web of Science ®Google Scholar
• HRUBAN RH, PETERSEN GM, GOGGINS M et al.: Familial pancreatic cancer. Ann. Oncol. (1999) 10(Suppl. 4):69-73.
   PubMedGoogle Scholar
• MURPHY KM, BRUNE KA, GRIFFIN C et al.: Evaluation of candidate genes MAP2K4,MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. (2002) 62(13):3789-3793.
   PubMed Web of Science ®Google Scholar
• GRUETZMANN R, MCFAUL C, BARTSCH DK et al.: No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma. Cancer Lett. (2004) 214(1):63-68.
   PubMed Web of Science ®Google Scholar
• BARTSCH DK, FENDRICH V, SLATER EP et al.: RNASEL germline variants are associated with pancreatic cancer. Int. J. Cancer (2005) 117(5):718-722.
   PubMed Web of Science ®Google Scholar
• BARTSCH DK, KRJUSEWSKI K, SINA-FREY M et al.: Low frequency of CHEK2 mutations in familial pancreatic cancer. Fam. Cancer (2006) 5(4):305-308.
   PubMed Web of Science ®Google Scholar
• NEJ K, BARTSCH DK, SINA-FREY M et al.: The NOD3020insC mutation and the risk of familial pancreatic cancer. Hered. Cancer Clin. Pract. (2004) 2:149-150.
   PubMedGoogle Scholar
• VAN DER HEIJDEN MS, YEO CJ, HRUBAN RH et al.: Fanconi anemia gene mutations in youngonset pancreatic cancer. Cancer Res. (2003) 63(10):2585-2588.
   PubMed Web of Science ®Google Scholar
• ROGERS CD, VAN DER HEIJDEN MS, BRUNE K et al.: The genetics of FANCC and FANCG in familial pancreatic cancer. Cancer Biol. Ther. (2004) 3(2):167-169.
   PubMed Web of Science ®Google Scholar
• CALIN GA, TRAPASSO F, SHIMIZU M et al.: Familial cancer associated with a polymorphism in ARLTS1. N. Engl. J. Med. (2005) 352(16):1667-1676.
   PubMed Web of Science ®Google Scholar
• SCHUTTE M, DA COSTA LT, HAHN SA et al.: Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA (1995) 92(13):5950-5954.
   PubMed Web of Science ®Google Scholar
• GOGGINS M, SCHUTTE M, LU J et al.: Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. (1996) 56(23):5360-5364.
   PubMed Web of Science ®Google Scholar
• HAHN SA, GREENHALF B, ELLIS I et al.: BRCA2 germline mutations in familial pancreatic carcinoma. J. Natl. Cancer Inst. (2003) 95(3):214-221.
   PubMed Web of Science ®Google Scholar
• MARTIN ST, MATSUBAYASHI H, ROGERS CD et al.: Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer. Oncogene (2005) 24(22):3652-3656.
   PubMed Web of Science ®Google Scholar
• COUCH FJ, JOHNSON MR, RABE KG et al.: The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. (2007) 16(2):342-346.
   PubMed Web of Science ®Google Scholar
• BRAND R, RUBINSTEIN C, LERCH MM et al.: Consensus guidelines for counselling patients at risk for developing pancreatic cancer. Pancreatology (In Press).
   Google Scholar
• MATSUBAYASHI H, CANTO M, SATO N et al.: DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res. (2006) 66(2):1208-1217.
   PubMed Web of Science ®Google Scholar
• RULYAK SJ, BRENTNALL TA: Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology (2001) 1(5):477-485.
   PubMed Web of Science ®Google Scholar
• CANTO MI, GOGGINS M, YEO CJ et al.: Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin. Gastroenterol. Hepatol. (2004) 2(7):606-621.
   PubMed Web of Science ®Google Scholar
• CANTO MI, GOGGINS M, HRUBAN RH et al.: Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin. Gastroenterol. Hepatol. (2006) 4(6):766-781.
   Google Scholar
• LANGER P, ROTHMUND M, BARTSCH DK: Prophylaktische chirurgie des pankreas. Chirurg (2006) 77:25-32.
   PubMed Web of Science ®Google Scholar